Key factors associated with 6‐thioguanine and 6‐methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.15894 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Tiphaine Adam de Beaumais und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Pharmacology and Pharmacogenetics, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, France. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aims
Azathioprine (AZA) and 6‐mercaptopurine are prescribed in acute lymphoblastic leukaemia (ALL) and inflammatory bowel diseases (IBD). Metabolism to active 6‐thioguanine (6TGN) and 6‐methylmercaptopurine nucleotides (6MMPN) is variable but therapeutic drug monitoring (TDM) remains debatable. This study reports on factors impacting on red blood cell (RBC) metabolites concentrations in children to facilitate TDM interpretation.
Methods
The first paediatric TDM samples received during year 2021 were analysed, whatever indication and thiopurine drug. Target concentration ranges were 200–500,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Pharmacology and Pharmacogenetics, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, France.
- Centre d'Etudes Périnatales de l'Océan Indien (UR 7388), Université de La Réunion, Saint-Pierre, France.
- University Paris Cité, Paris, France.
- Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Assistance Publique - Hôpitaux de Paris, France.
- Sorbonne University, Paris, France.
- Department of Pediatric Gastroenterology and Nutrition, Hôpital Robert Debré, Assistance Publique - Hôpitaux de Paris, France.
ORCID-Profile: Evelyne Jacqz-Aigrain
Zitieren
APA
de Beaumais, T. A., Lorrain, S., Mamhoudi, N., Simonin, M., Martinez Vinson, C., Medard, Y., Petit, A., & Jacqz-Aigrain, E. (2024). Key factors associated with 6‐thioguanine and 6‐methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15894
Vancouver
de Beaumais TA, Lorrain S, Mamhoudi N, Simonin M, Martinez Vinson C, Medard Y, et al. Key factors associated with 6‐thioguanine and 6‐methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.15894
BibTeX
@article{deBeaumais2024,
author = {de Beaumais, Tiphaine Adam and Lorrain, Simon and Mamhoudi, Naura and Simonin, Mathieu and Martinez Vinson, Christine and Medard, Yves and Petit, Arnaud and Jacqz-Aigrain, Evelyne},
title = {Key factors associated with 6‐thioguanine and 6‐methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.15894}
}
EUVIMED